Oxycodone Completed Phase 1 Trials for Pain, Chronic Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT03398330OTR Tablet 40 mg Fed-state Bioequivalence Study
NCT03403504OTR Tablet 10 mg Fasted-state Bioequivalence Study
NCT02880475OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients